IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 2, Issue 1 (2021)
J Clinic Care Skill 2021, 2(1): 15-19 |
Back to browse issues page
Article Type:
History
Received: 2020/04/5 | Accepted: 2020/09/3 | Published: 2021/01/20
Received: 2020/04/5 | Accepted: 2020/09/3 | Published: 2021/01/20
How to cite this article
Pouzesh M, Nakhaee Moghadam M, Davoodi M. Relationship between Maternal Serum Biomarkers (HCG, AFP, UE3, and Inhibin A) in the Second Trimester of Pregnancy and Preterm Labor. J Clinic Care Skill 2021; 2 (1) :15-19
URL: http://jccs.yums.ac.ir/article-1-87-en.html
URL: http://jccs.yums.ac.ir/article-1-87-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
2- Department of Obstetrics and Gynecology, Maternal and Fetal Health Research Center, Zabol University of Medical Sciences, Zabol, Iran
2- Department of Obstetrics and Gynecology, Maternal and Fetal Health Research Center, Zabol University of Medical Sciences, Zabol, Iran
Abstract (1659 Views)
Aims: Preterm labor (PTL) is one of the most important medical community problems and the main cause of infant morbidity and mortality after congenital anomalies. Several studies have shown a significant association between the abnormal levels of quadruple test with PTL. However, there is no general agreement on the value of quadruple tests for predicting complications among studies. This study aimed to determine the diagnostic accuracy of maternal serum biochemical markers (HCG, AFP, UE3, and Inhibin A) in the second trimester of pregnancy and their effect on PTL.
Methods & Methods: This longitudinal study was performed on 240 pregnant women who underwent quad-marker testing in the second trimester of pregnancy in Yasuj in 2019. Pregnancy and labor information was followed up and recorded in a checklist. Also, ROC (Receiver Operative Characteristics) was used to determine the test efficiency in PTL and the optimum point with the highest sensitivity and specificity. All analyses were performed using SPSS 22 software.
Findings: 19 pregnant mothers (7.9%) had PTL. The best amount of AFP to detect PTL with a sensitivity of 72% and a specificity of 68% was estimated at 1.515. The best values of Inhibin A and HCG were also estimated at 1.245 and 0.885, respectively.
Conclusion: Of the quadruple tests, three AFP tests, HCG and inhibin, effectively diagnose PTL during pregnancy.
Methods & Methods: This longitudinal study was performed on 240 pregnant women who underwent quad-marker testing in the second trimester of pregnancy in Yasuj in 2019. Pregnancy and labor information was followed up and recorded in a checklist. Also, ROC (Receiver Operative Characteristics) was used to determine the test efficiency in PTL and the optimum point with the highest sensitivity and specificity. All analyses were performed using SPSS 22 software.
Findings: 19 pregnant mothers (7.9%) had PTL. The best amount of AFP to detect PTL with a sensitivity of 72% and a specificity of 68% was estimated at 1.515. The best values of Inhibin A and HCG were also estimated at 1.245 and 0.885, respectively.
Conclusion: Of the quadruple tests, three AFP tests, HCG and inhibin, effectively diagnose PTL during pregnancy.
Keywords:
References
1. Tavasolian F, Abdollahi E, Vakili M, Samadi M. Investigating the correlation between c-reactive protein and preterm delivery. Iran J Obstet Gynecol Infertility. 2014;17(102):1-6. [Persian]
2. Raeesian F, Lamiyan M, Hajizadeh E, Bakouie S, Soltanmoradi S, Moghaddam Banaem L, et al. Serum zinc & iron in the first half of pregnancy and their relationship with preterm delivery: A prospective longitudinal study. J Res Dev Nurs Midwifery. 2015;12(1):39-46. [Persian]
3. Sehat Z, Goshetasbi A, Taheri Amin M. Investigating association between second trimester maternal serum biomarkers and pre-term delivery. Iran J Reprod Med. 2013;11(2):127-32. [Persian]
4. Roghaei MA, Sabahi R, Ghasemi M. Studying the combination of cervical interleukins-6 and-8 with cervical dilatation in predicting preterm labor. J Isfahan Med Sch. 2009;27(94):127-33. [Persian]
5. Ajam ME, Nikkhah Shahmirzadi A, Nikkhah A. Evaluate the prevalence of premature labor and its related factors in the Shahrood in 2012. J Health Breeze. 2014;2(3):43-8. [Persian]
6. Kazemi Aghdam M, Zadehmodares SH, Zham H. Histologic evaluation of subclinical chorioamnionitis associated with preterm labor at Mahdieh hospital in Tehran. PEJOUHANDEH. 2005;10(4):227-30. [Persian]
7. Lao MR, Calhoun BC, Bracero LA, Wang Y, Seybold DJ, Broce M, et al. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population. J Med Screen. 2009;16(2):55-9. [DOI:10.1258/jms.2009.009017] [PMID]
8. Nakhaee Moghadam M, Davoodi M, Behzadmehr R. Unjustified abnormalities of analytes in the second trimester. Int J Med Health Res. 2018;4(3):19-21.
9. Feyzbakhsh S, Mozaffari R, Tajik A, Zafarnia M, Fardmanesh A. Triple test and pregnancy outcome association. Natural and Applied Sciences. 2013;4(1):368-71.
10. Kim SY, Kim SK, Lee JS, Kim IK, Lee K. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome. Yonsei Med J. 2000;41(2):226-9. [DOI:10.3349/ymj.2000.41.2.226] [PMID]
11. Yazdani S, Rouholahnejad R, Asnafi N, Sharbatdaran M, Zakershob M, Bouzari Z. Correlation of pregnancy outcome with quadruple screening test at second trimester. Med J Islam Repub Iran. 2015;29:281. [Persian]
12. Duric K, Skrablin S, Lesin J, Kalafatic D, Kuvacic I, Suchanek E. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):12-5. [DOI:10.1016/S0301-2115(03)00081-2]
13. Shaw SWS, Chen CP, Cheng PJ. From down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan. Taiwan J Obstet Gynecol. 2013;52(4):470-4. [DOI:10.1016/j.tjog.2013.10.003] [PMID]
14. Nakhaee Moghadam M, Jahantigh HA, Azimi E, Davoodi M, Rezaie Keikhaie K. The predictive value of quadruple tests in the second trimester of pregnancy in identifying pregnancy complications. Ann Med Health Sci Res. 2018;8:139-42.
15. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106(2):260-7. [DOI:10.1097/01.AOG.0000172419.37410.eb] [PMID]
16. Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med. 1999;341(27):2033-8. [DOI:10.1056/NEJM199912303412701] [PMID]
17. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, et al. Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999;181(4):968-74. [DOI:10.1016/S0002-9378(99)70334-0]